Aspergillosis research is evolving rapidly, including the development of new antifungal medicines, biologic treatments, diagnostic tests, monitoring approaches and ways to improve respiratory health and quality of life.
Research findings do not necessarily mean that a new test or treatment is ready for routine clinical use. Studies may be at very different stages, from laboratory and animal research through clinical trials to evidence that could influence future guidelines and patient care.
This hub brings together recent aspergillosis research and explains what new findings may mean for patients, carers and healthcare professionals. We aim to distinguish promising early research from developments that are closer to changing clinical practice.
Research to Watch
These selected developments may be especially interesting or potentially important for people with aspergillosis and for anyone wanting to understand how care may change.
Each article explains what is new, why it might matter, how close it may be to clinical use, and what remains uncertain.
Nothing found.
Additional Research Articles
Topics in This Hub
Latest Research Articles
🧾 Rezafungin: A New Antifungal Being Trialled for CPA
August 1, 2025
🔬 Emerging Research for Aspergillosis
July 30, 2025
Biologics and Long Term Side Effects
July 14, 2025
🧪 Why Are Some Studies So Small?
July 4, 2025
Research Outcomes Explained: 2025
July 1, 2025
🧬 Are Vaccines for Aspergillosis on the Horizon?
June 30, 2025
🫁 Why Your Voice Matters in Research
June 23, 2025
🫁 Inhaled Amphotericin: What You Need to Know
June 2, 2025
Could You Help Transform the Future of CPA Treatment?
April 25, 2025
Understanding How Our Lungs Fight Fungus
April 15, 2024
Do you have asthma and Allergic Bronchopulmonary Aspergillosis?
November 6, 2023
Fungal vaccine developments
March 22, 2023
Did this page help you?
Tell us in one minute
















